CRBP logo

CRBP

Corbus Pharmaceuticals Holdings Inc.

$9.37
-$0.53(-5.35%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$122.92M
Volume
90.41K
52W Range
$4.64 - $61.72
Target Price
$41.00
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$648.4K$1.9M$2.4M$4.8M$36.1M$3.9M$881.7K------
Total Revenue
$648.4K$1.9M$2.4M$4.8M$36.1M$3.9M$881.7K------
GROSS PROFIT
Gross Profit
$648.4K$1.9M$2.4M$4.8M$36.1M$3.9M$881.7K------
OPERATING EXPENSES
Operating Expenses
$-9.5M$-21.9M$-35.0M$-61.6M$113.2M$126.7M$56.9M$34.8M$45.1M$48.7M
Research & Development
$5.9M$15.4M$26.0M$48.6M$89.6M$98.3M$36.4M$16.1M$31.2M$32.2M
Research Expense
$5.9M$15.4M$26.0M$48.6M$89.6M$98.3M$36.4M$16.1M$31.2M$32.2M
Selling, General & Administrative
$3.6M$6.5M$9.0M$13.0M$23.6M$28.5M$20.4M$18.7M$13.9M$16.5M
General & Administrative Expenses
$3.6M$6.5M$9.0M$13.0M$23.6M$28.5M$20.4M$18.7M$13.9M$16.5M
Salaries & Wages
$-1.2M$-3.2M$-5.7M$-7.6M$-12.0M$12.5M$9.5M$5.7M$3.5M$6.1M
Depreciation & Amortization
$-44.0K$-87.7K$-255.7K$-493.9K$-739.4K$1.1M$1.0M$763.0K$600.0K$600.0K
Depreciation & Amortization
$-44.0K$-87.7K$-255.7K$-493.9K$-739.4K$1.1M$1.0M$763.0K$600.0K$600.0K
Other Operating Expenses
--$-21.9M$-35.0M--$-1.0M$1.2M$1.2M$39.8M$45.1M$48.7M
OPERATING INCOME
Operating income
$-8.9M$-20.0M$-32.6M$-56.7M$-77.1M$-122.8M$-56.0M$-39.8M$-45.1M$-48.7M
EBITDA
$-8.8M$-19.9M$-32.2M$-55.2M$-71.5M$-121.1M$-54.3M$-34.1M$-39.3M$-37.4M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$-2.4K$-3.1K$-3.6K--$-1.2M$1.0M$1.8M$2.1M$3.8M$1.8M
Intinc
$977$477$183.1K$982.8K$4.6M----------
Net Non-Operating Interest Income/Expense
$977$477$183.1K$982.8K$5.8M$-1.0M$-1.8M$-2.1M$-3.8M$-1.8M
Gain on Sale of Securities
----------$-251.0K$663.3K$96.8K$1.6M$6.3M
Other Income/Expense
------$-6.2M$-4.6M$-13.0M$-12.5M$-5.4M$-4.5M$-10.4M
Other Special Charges
------$6.2M$4.6M$13.3M$11.9M$-48.8K$2.7M$4.1M
SPECIAL ITEMS
Special Income Charges
--------------$-5.0M----
PRE-TAX INCOME
EBIT
$-8.9M$-20.0M$-32.4M$-55.7M$-72.7M$-122.8M$-56.0M$-34.8M$-40.8M$-38.4M
Pre-Tax Income
$-8.9M$-20.0M$-32.4M$-55.7M$-71.5M$-111.3M$-45.7M$-42.3M$-40.6M$-40.2M
NET INCOME
Net Income
$-8.9M$-20.0M$-32.4M$-55.7M$-71.5M$-111.3M$-45.6M$-42.3M$-44.6M$-40.2M
Net Income (Continuing Operations)
$-8.9M$-20.0M$-32.4M$-55.7M$-71.5M$-111.3M$-45.6M$-42.3M$-44.6M$-40.2M
Net Income (Discontinued Operations)
$-8.9M$-20.0M$-32.4M$-55.7M$-71.5M$-111.3M$-45.6M$-42.3M$-44.6M$-40.2M
Net Income (Common Stockholders)
$-8.9M$-20.0M$-32.4M$-55.7M$-71.5M$-111.3M$-45.6M$-42.3M$-44.6M$-40.2M
Normalized Income
------------$-36.1M----$-37.9M
TOTALS
Total Expenses
$-9.5M$-21.9M$-35.0M$-61.6M$113.2M$126.7M$56.9M$34.8M$45.1M$48.7M
SHARE & EPS DATA
Average Shares Outstanding
$1.0M$1.4M$1.7M$1.9M$2.1M$2.6M$4.1M$4.2M$4.3M$10.9M
Average Shares Outstanding (Diluted)
$1.1M$1.4M$1.7M$1.9M$2.1M$2.6M$4.1M$4.2M$4.3M$10.9M
Shares Outstanding
$1.3M$1.6M$1.9M$2.1M$2.4M$4.2M$4.2M$4.2M$10.5M$12.3M
Basic EPS
----------$-42.6$-11.1$-10.15$-10.31$-3.68
Basic EPS (Continuing Operations)
----------$-42.6$-11.1$-10.15$-10.31$-3.68
Diluted EPS
$-8.4$-14.7$-19.5$-29.4$-33.6$-42.6$-11.1$-10.15$-10.31$-3.68
Diluted EPS (Continuing Operations)
--------$-33.6----$-10.15$-10.31$-3.68
OTHER METRICS
Net Income Discontinuous Operations
--$34.5K----------------
Non Recurring Operation Expense
--------------$5.0M----
Other Gand A
$3.6M$6.5M$9.0M$13.0M$23.6M$28.5M$20.4M$18.7M$13.9M$16.5M
Provision For Gain Loss On Disposal
--$34.5K----------------
Rent And Landing Fees
$3.6M$6.5M$9.0M$13.0M$-1.1M------$-1.7M$-1.7M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CRBP$9.37-5.4%90.41K
3
4
5
6

Get Corbus Pharmaceuticals Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.